Pfizer, Ranbaxy strike deal over generic Lipitor

06/18/2008 | Bloomberg ·

Pfizer and India-based Ranbaxy Laboratories Ltd. have agreed to delay the U.S. launch of a generic version of cholesterol drug Lipitor until November 2011. The lawsuit settlement also allows the sale of Ranbaxy's generic Lipitor in seven major drug markets, including Australia and Canada, and gives Pfizer 20 more months to find new products that can help offset as much as $12 billion of revenue at risk once Lipitor copies become available.

View Full Article in:

Bloomberg ·

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA